These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 38731401)

  • 1.
    Oyinloye BE; Shamaki DE; Agbebi EA; Onikanni SA; Ubah CS; Aruleba RT; Dao TNP; Owolabi OV; Idowu OT; Mathenjwa-Goqo MS; Esan DT; Ajiboye BO; Omotuyi OI
    Molecules; 2024 Apr; 29(9):. PubMed ID: 38731401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-Based Study of Natural Products with Anti-Schistosoma Activity.
    Akachukwu I; Olubiyi OO; Kosisochukwu A; John MC; Justina NN
    Curr Comput Aided Drug Des; 2017; 13(2):91-100. PubMed ID: 28103771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macromolecular bases of antischistosomal therapy.
    Angelucci F; Miele AE; Boumis G; Brunori M; Dimastrogiovanni D; Bellelli A
    Curr Top Med Chem; 2011; 11(16):2012-28. PubMed ID: 21619508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of Lead Compounds Targeting the Selenoprotein Thioredoxin Glutathione Reductase for Treatment of Schistosomiasis.
    Lyu H; Petukhov PA; Banta PR; Jadhav A; Lea WA; Cheng Q; Arnér ESJ; Simeonov A; Thatcher GRJ; Angelucci F; Williams DL
    ACS Infect Dis; 2020 Mar; 6(3):393-405. PubMed ID: 31939288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-throughput screening against thioredoxin glutathione reductase identifies novel inhibitors with potential therapeutic value for schistosomiasis.
    Li T; Ziniel PD; He PQ; Kommer VP; Crowther GJ; He M; Liu Q; Van Voorhis WC; Williams DL; Wang MW
    Infect Dis Poverty; 2015 Aug; 4():40. PubMed ID: 26341081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thioredoxin glutathione reductase from Schistosoma mansoni: an essential parasite enzyme and a key drug target.
    Kuntz AN; Davioud-Charvet E; Sayed AA; Califf LL; Dessolin J; Arnér ES; Williams DL
    PLoS Med; 2007 Jun; 4(6):e206. PubMed ID: 17579510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and evaluation of 1,4-naphthoquinone ether derivatives as SmTGR inhibitors and new anti-schistosomal drugs.
    Johann L; Belorgey D; Huang HH; Day L; Chessé M; Becker K; Williams DL; Davioud-Charvet E
    FEBS J; 2015 Aug; 282(16):3199-217. PubMed ID: 26111549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural basis for the function and inhibition of dihydroorotate dehydrogenase from Schistosoma mansoni.
    de Mori RM; Aleixo MAA; Zapata LCC; Calil FA; Emery FS; Nonato MC
    FEBS J; 2021 Feb; 288(3):930-944. PubMed ID: 32428996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular docking to explore the possible binding mode of potential inhibitors of thioredoxin glutathione reductase.
    Huang J; Hua W; Li J; Hua Z
    Mol Med Rep; 2015 Oct; 12(4):5787-95. PubMed ID: 26239395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Will new antischistosomal drugs finally emerge?
    Cioli D; Valle C; Angelucci F; Miele AE
    Trends Parasitol; 2008 Sep; 24(9):379-82. PubMed ID: 18675590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unveiling potent inhibitors for schistosomiasis through ligand-based drug design, molecular docking, molecular dynamics simulations and pharmacokinetics predictions.
    Ja'afaru SC; Uzairu A; Bayil I; Sallau MS; Ndukwe GI; Ibrahim MT; Moin AT; Mollah AKMM; Absar N
    PLoS One; 2024; 19(6):e0302390. PubMed ID: 38923997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New praziquantel derivatives containing NO-donor furoxans and related furazans as active agents against Schistosoma mansoni.
    Guglielmo S; Cortese D; Vottero F; Rolando B; Kommer VP; Williams DL; Fruttero R; Gasco A
    Eur J Med Chem; 2014 Sep; 84():135-45. PubMed ID: 25016371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of oxadiazoles as new drug leads for the control of schistosomiasis.
    Sayed AA; Simeonov A; Thomas CJ; Inglese J; Austin CP; Williams DL
    Nat Med; 2008 Apr; 14(4):407-12. PubMed ID: 18345010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [(η(6)-Praziquantel)Cr(CO)3] derivatives with remarkable in vitro anti-schistosomal activity.
    Patra M; Ingram K; Pierroz V; Ferrari S; Spingler B; Gasser RB; Keiser J; Gasser G
    Chemistry; 2013 Feb; 19(7):2232-5. PubMed ID: 23296750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In silico identification and evaluation of potential interaction of Azadirachta indica phytochemicals with Plasmodium falciparum heat shock protein 90.
    Daniyan MO; Ojo OT
    J Mol Graph Model; 2019 Mar; 87():144-164. PubMed ID: 30544005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure mechanism insights and the role of nitric oxide donation guide the development of oxadiazole-2-oxides as therapeutic agents against schistosomiasis.
    Rai G; Sayed AA; Lea WA; Luecke HF; Chakrapani H; Prast-Nielsen S; Jadhav A; Leister W; Shen M; Inglese J; Austin CP; Keefer L; Arnér ES; Simeonov A; Maloney DJ; Williams DL; Thomas CJ
    J Med Chem; 2009 Oct; 52(20):6474-83. PubMed ID: 19761212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of New Anti-Schistosomal Hits by Integration of QSAR-Based Virtual Screening and High Content Screening.
    Neves BJ; Dantas RF; Senger MR; Melo-Filho CC; Valente WC; de Almeida AC; Rezende-Neto JM; Lima EF; Paveley R; Furnham N; Muratov E; Kamentsky L; Carpenter AE; Braga RC; Silva-Junior FP; Andrade CH
    J Med Chem; 2016 Aug; 59(15):7075-88. PubMed ID: 27396732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thioredoxin glutathione reductase as a novel drug target: evidence from Schistosoma japonicum.
    Song L; Li J; Xie S; Qian C; Wang J; Zhang W; Yin X; Hua Z; Yu C
    PLoS One; 2012; 7(2):e31456. PubMed ID: 22384025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potent Inhibitors of Thioredoxin Glutathione Reductase: Grail of Anti-Schistosome Drug within Reach?
    Tripathi T; Chetri PB
    ACS Infect Dis; 2020 May; 6(5):893-895. PubMed ID: 32159329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis, anti-schistosomal activity and molecular docking of novel 8-hydroxyquinoline-5-sufonyl 1,4-diazepine derivatives.
    Eweas AF; Allam G; Abuelsaad AS; ALGhamdi AH; Maghrabi IA
    Bioorg Chem; 2013 Feb; 46():17-25. PubMed ID: 23247256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.